Metronomic chemotherapy offsets HIFα induction upon maximum‐tolerated dose in metastatic cancers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Metronomic chemotherapy offsets HIFα induction upon maximum‐tolerated dose in metastatic cancers

Published:2020-07-20 Issue:9 Volume:12 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Schito Luana¹²³^ORCID,Rey Sergio¹²,Xu Ping³,Man Shan³,Cruz‐Muñoz William³,Kerbel Robert S³⁴^ORCID

Affiliation:

1. UCD School of Medicine University College Dublin Dublin 4 Ireland

2. UCD Conway Institute of Biomolecular & Biomedical Research University College Dublin Belfield, Dublin 4 Ireland

3. Biological Sciences Platform Sunnybrook Research Institute Toronto ON Canada

4. Department of Medical Biophysics University of Toronto Toronto ON Canada

Funder

Canadian Institutes of Health Research

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.201911416

Reference45 articles.

1. SurvExpress: An Online Biomarker Validation Tool and Database for Cancer Gene Expression Data Using Survival Analysis

2. Metronomic Maintenance Therapy for Rhabdomyosarcoma

3. Maintenance low-dose chemotherapy in patients with high-risk (HR) rhabdomyosarcoma (RMS): A report from the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG).

4. Expression of HIF-1alpha and VEGF in colorectal cancer: association with clinical outcomes and prognostic implications

5. Tumor Cells Upregulate Normoxic HIF-1α in Response to Doxorubicin

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metronomic chemotherapy: bridging theory to clinical application in canine and feline oncology;Frontiers in Veterinary Science;2024-06-06

2. Optimizing cancer therapy: a review of the multifaceted effects of metronomic chemotherapy;Frontiers in Cell and Developmental Biology;2024-05-15

3. Antiangiogenic–immune-checkpoint inhibitor combinations: lessons from phase III clinical trials;Nature Reviews Clinical Oncology;2024-04-10

4. Metronomic chemotherapy in cancer treatment: new wine in an old bottle;Theranostics;2024

5. HOXA9 transcription factor is a double-edged sword: from development to cancer progression;Cancer and Metastasis Reviews;2023-12-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3